Loading
Life sciences · Review
Journal of Oncology Pharmacy Practice · September 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Introduction This study aimed to systematically evaluate the association between adverse drug reactions, medication adherence, and outpatient treatment outcomes among women with breast cancer receiving oral anticancer therapies. Methods A systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and guided by the Joanna Briggs Institute methodology. A comprehensive literature search was performed in PubMed, CINAHL Ultimate, Embase, MEDLINE, and Scopus to identify quantitative observational studies published in English from database inception through June 2026. Eligible studies examined the association between adverse drug reactions and medication adherence and/or outpatient treatment outcomes in female patients with breast cancer receiving oral anticancer therapies. Cohort, case-control, and cross-sectional studies conducted in outpatient settings were included. Two independent reviewers screened studies, extracted data, and assessed methodological quality using Joanna Briggs Institute critical appraisal tools. Meta-analyses were conducted when sufficient clinical and methodological homogeneity was present. Results Forty studies involving 44,455 women were included; all evaluated oral endocrine therapy. Adverse drug reactions were associated with lower medication adherence, although substantial between-study heterogeneity limited confidence in the magnitude and generalizability of the pooled association. Evidence linking adverse drug reactions with outpatient treatment outcomes, including disease-free survival, was limited and heterogeneous, with no consistent association identified. Conclusions Adverse drug reactions were associated with medication nonadherence among women receiving oral endocrine therapy. However, the very high heterogeneity of the adherence synthesis and the observational nature of the included studies preclude a precise common-effect or causal interpretation.